Thyroid transcription factor 1 and napsin A double staining in lung adenocarcinoma in pleural fluid

Acta Cytologica

Volumn 56, Issue 4, 2012, Pages 425-430

  Liu, Lian ^a   Cohen, Cynthia ^a   Siddiqui, Momin T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Napsin A; Pleural fluid; Thyroid transcription factor 1

Indexed keywords

NAPSIN A; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CLINICAL ARTICLE; DOUBLE STAINING; ESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; OVARY ADENOCARCINOMA; PLEURA BIOPSY; PLEURA FLUID; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STAINING;

EID: 84864221636     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000337439     Document Type: Article

References (25)

1. Sears D, Hajdu SI: The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987;31:85-97.
2. Johnston WW: The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-909.
3. Sangodkar J, Katz S, Melville H, Narla G: Lung adenocarcinoma: lessons in translation from bench to bedside. Mt Sinai J Med 2010;77:597-605.
4. Moran, C: Importance of molecular features of non-small cell lung cancer for choice of treatment. Am J Pathol 2011;178;1940-1948.
5. Bishop JA, Sharma R, Illei PB: Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 2010;41:20-25.
6. Chang YL, Lee YC, Liao WY, Wu CT: The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 2004;44:149-157.
7. Dennis JL, et al: Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005;11:3766-3772.
8. Harlamert HA, et al: Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol 1998;42:1382-1388.
9. Khoor A, Whitsett JA, Stahlman MT, Olson SJ, Cagle PT: Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 1999;30:695-700.
10. Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS: The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001;116:483-488.
11. Liu J, Farhood A: Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations. Cancer 2004;102:109-114.
12. Suzuki A, et al: Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract 2005;201:579-586.
13. Ueno T, Linder S, Elmberger G: Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer 2003;88:1229-1233.
14. Fatima N, Cohen C, Lawson D, Siddiqui MT: TTF-1 and napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Cancer Cytopathol 2011;119:127-133.
15. Devesa SS, Bray F, Vizcaino AP, Parkin DM: International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-299.
16. Stoll LM, et al: The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol 2010;118:441-449.
17. Afify AM, al-Khafaji BM: Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Acta Cytol 2002;46:675-678.
18. Jang KY, Kang MJ, Lee DG, Chung MJ: Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Anal Quant Cytol Histol 2001;23:400-404.
19. Ng WK, Chow JC, Ng PK: Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens. Cancer 2002;96:43-48.
20. Gomez-Fernandez C, Jorda M, Delgado PI, Ganjei-Azar P: Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids. Cancer 2002;96:289-293.
21. Dejmek A, et al: Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Diagn Cytopathol 2007;35:493-497.
22. Kim JH, Kim YS, Choi YD, Lee JS, Park CS: Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Acta Cytol 2011;55:266-270.
23. Mukhopadhyay S, Katzenstein AL: Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011;35:15-25.
24. Vassilopoulou-Sellin R, Sneige N: Pleural effusion in patients with differentiated papillary thyroid cancer. South Med J 1994;87:1111-1116.
25. Renshaw AA, Comiter CV, Nappi D, Granter SR: Effusion cytology of renal cell carcinoma. Cancer 1998;84:148-152.